Amanote Research
Register
Sign In
Symtomatic Factors in Patients With Major Depressive Disorder (MDD): Results From an Observational Study
Value in Health
- United Kingdom
doi 10.1016/j.jval.2014.08.1753
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
November 1, 2014
Authors
D. Novick
W. Montgomery
J. Aguado
H. Dueñas
J.M. Haro
Publisher
Elsevier BV
Related search
Pharmacogenetics of Major Depressive Disorder (MDD): Progress in Two Serotonergic Targets
University of Ottawa Journal of Medicine
Dental Patients With Major Depressive Disorder
Current Oral Health Reports
PMH42 Assessing Impacts of Major Depressive Disorder (MDD) on Cognitive Function
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Dream Contents in Patients With Major Depressive Disorder
Canadian Journal of Psychiatry
Psychiatry
Mental Health
Hypothyroidism in Patients With Asthma and Major Depressive Disorder
The Primary Care Companion to The Journal of Clinical Psychiatry
Prospective Study of Risk Factors for Attempted Suicide Among Patients With DSM-IV Major Depressive Disorder
British Journal of Psychiatry
Medicine
Psychiatry
Mental Health
Acetyl-L-Carnitine Deficiency in Patients With Major Depressive Disorder
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Trial of SAGE-217 in Patients With Major Depressive Disorder
New England Journal of Medicine
Medicine
Efficacy, Safety and Tolerability of Escitalopram in Doses Up to 50 Mg in Major Depressive Disorder (MDD): An Open-Label, Pilot Study
BMC Psychiatry
Psychiatry
Mental Health